P G Conaghan

发表

A systematic review of ultrasonography in osteoarthritis

H. Keen, P. Conaghan, R. Wakefield, 2009, Annals of the rheumatic diseases.

The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement.

C Combescure, M. Suarez‐Almazor, M. Dougados, 2011, Osteoarthritis and cartilage.

What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?

A Guermazi, J A Kanis, C Peterfy, 2013, Annals of the rheumatic diseases.

Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review.

D J Hunter, J. Katz, E. Losina, 2011, Osteoarthritis and cartilage.

The role of imaging modalities in the diagnosis, differential diagnosis and clinical assessment of peripheral joint osteoarthritis.

P. Conaghan, A. Grainger, P G Conaghan, 2014, Osteoarthritis and cartilage.

Definition of osteoarthritis on MRI: results of a Delphi exercise.

F Eckstein, A Guermazi, T J Mosher, 2010, Osteoarthritis and cartilage.

MRI and non-cartilaginous structures in knee osteoarthritis.

S Totterman, G. Gold, D. Felson, 2006, Osteoarthritis and cartilage.

Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine.

P. Brooks, P. Conaghan, P G Conaghan, 1995, Current opinion in rheumatology.

Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group.

D J Hunter, E. Losina, D. Hunter, 2011, Osteoarthritis and cartilage.

DISEASE MODIFYING ANTIRHEUMATIC DRUGS

P G Conaghan, P Brooks, E Li, 1998, Current opinion in rheumatology.